Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 2, 2005 - Issue 4
Submit an article Journal homepage
48
Views
14
CrossRef citations to date
0
Altmetric
Review

Delivery of plant-derived vaccines

Stephen J Streatfield Applied Biotechnology Institute, 101 Gateway Boulevard, Suite 100, College Station, TX 77845, USA. [email protected]
Pages 719-728 | Published online: 11 Aug 2005

Bibliography

  • ELDRIDGE JH, STAAS JK,MEULBROEK JA, TICE TR, GILLEY RM: Biodegradable and biocompatible poly(m.-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhance the level of toxin-neutralizing antibodies. Infect. Immun. (1991) 59:2978–2985.
  • JACKSON S, MESTECKY J, CHILDERS NK, MICHALEK SM: Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect. Immun. (1990) 58:1932–1936.
  • MALLETT CP, HALE TL, KAMINSKI RW et al.: Intranasal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection. Infect. Immun. (1995) 63:2382–2386.
  • VERG L, HERRINGTON DA,MURPHY JR, WASSERMAN SS, FORMAL SB, LEVINE MM: Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shi gella sonnei vaccine or infection by pathogenic S. sonnei. Infect. Immun. (1990) 58:2002–2004.
  • RYAN ET, BUTTERTON JR, SMITH RN, CARROLL PA, CREAN TI, CALDERWOOD SB: Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live attenuated Vibrio cholerae vector strain. Infect. Immun. (1997) 65:2941–2949.
  • LAMPHEAR BJ, STREATFIELD SJ, JILKA JM et al.: Delivery of subunit vaccines in maize seed. J. Control. Release (2002) 85:169–180.
  • •Stability of corn-based vaccines during storage.
  • STREATFIELD SJ, HOWARD JA: Plant- based vaccines. Int. J. ParasitoL (2003) 33:479–493.
  • •Review of expression technologies and efficacy attained with plant-based vaccines.
  • BORISJUK LG, LOGENDRA S, PETERSEN F, GLEBA Y, RASKIN I: Production of recombinant proteins in plant root exudates. Nat. BiotechnoL (1999) 17:466–469.
  • FISCHER R, LIAO YC, DROSSARD J: Affinity purification of a TMV-specific recombinant full-size antibody from a transgenic tobacco suspension culture. ImmunoL Methods (1999) 226:1-10. 10.DANIELL H, LEE S- PANCHAI T, WIEBE PO: Expression of the native cholera toxin B subunit gene and assembly of functional oligomers in transgenic tobacco chloroplasts. J. Mol. BioL (2001) 311:1001–1009.
  • •High level of antigen attained using chloroplast expression.
  • YUSIBOV V, MODELSKA A, STEPLEWSKI K et al.: Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc. Natl. Acad. Sci. USA (1997) 94:5784–5788.
  • HOOD EE, WITCHER DR, MADDOCK S et al.: Commercial production of avidin from transgenic maize: characterization of transformant, production, processing, extraction and purification. Mol. Breed. (1997) 3:291–306.
  • WOODARD SL, MAYOR JM, BAILEY MR et al.: Maize-derived bovine trypsin: characterization of the first large-scale, commercial protein product from transgenic plants. BiotechnoL AppL Biochem. (2003) 37:1–8.
  • ZHONG G-Y, PETERSON D, DELANEY DE et al.: Commercial production of aprotinin in transgenic maize seeds. Mol. Breed. (1999) 5:345–356.
  • WIGDOROVITZ A, FILGUEIRA DM, ROBERTSON N et al.: Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic vurus expressing the FMDV structural protein VP1. Virology (1999) 264:85–91.
  • STREATFIELD SJ, JILKA JM, HOOD EEet al.: Plant-based vaccines: unique advantages. Vaccine (2001) 19:2742–2748.
  • WIGDOROVITZ A, CARRILLO C, DUS SANTOS MJ et al.: Induction of a protective antibody response to foot and mouth disease in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology (1999) 255:347–353.
  • KAPUSTA J, MODELSKA A, PNIEWSKI T et al.: A plant-derived edible vaccine against hepatitis B virus. FASEB J. (1999) 13:1796–1799.
  • •Clinical trial using lettuce.
  • YUSIBOV V, HOOPER DC, SPITSIN SV et al.: Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine (2002) 20:3155–3164.
  • •Expression in a plant viral system leading to a clinical trial using spinach.
  • ARAKAWA T, CHONG DK, MERRITT JL, LANGRIDGE WH: Expression of cholera toxin B subunit oligomers in transgenic potato plants. Transgenic Res. (1997) 6: 403–413.
  • MASON HS, HAQ TA, CLEMENTS JD, ARNTZEN CJ: Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene. Vaccine (1998) 16:1336–1343.
  • SANDHU JS, KRASNYANSKI SF, DOMIER LL, KORBAN SS, OSADJAN MD, BUETOW DE: Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Res. (2000) 9:127–135.
  • HOOD EE, BAILEY MR, BEIFUSS K et al.: Criteria for high-level expression of a fungal laccase gene in transgenic maize. Plant BiotechnoL J. (2003) 1:129–140.
  • CHIKWAMBA R, MCMURRAY J, SHOU H et al.: Expression of a synthetic E. coli heat-labile enterotoxin B subunit (LT-B) in maize. Mol. Breed. (2002) 10:253–265.
  • RICHTER, LJ, THANAVALA Y, ARNTZEN CJ, MASON HS: Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. BiotechnoL (2000) 18:1167–1171.
  • STREATFIELD SJ, LANE JR, BROOKS CA et al.: Corn as a production system for human and animal vaccines. Vaccine (2003) 21:812–815.
  • ARAKAWA T, YU J, CHONG DK, HOUGH J, ENGEN PC, LANGRIDGE WH: A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes. Nat. BiotechnoL (1998) 16:934–938.
  • RIGANO MM, ALVAREZ ML, JIN Y et al.: Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. Plant Cell Rep. (2003) 21:1020–1026.
  • •Plant-based vaccine candidate with the antigen fused to a carrier.
  • RIGANO MM, ALVAREZ ML, PINKHASOV J et al.: Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. Plant Cell Rep. (2004) 22:502–508.
  • •Plant-based vaccine candidate with the antigen fused to a carrier.
  • HAQ TA, MASON HS, CLEMENTS JD, ARNTZEN CJ: Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science (1995) 268:714–716.
  • SOJIKUL P, BUEHNER N, MASON HS: A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells. Proc. NatL Acad. Sci. USA (2003) 100: 2209–2214.
  • MASON HS, LAM DM, ARNTZEN CJ: Expression of hepatitis B surface antigen in transgenic plants. Proc. NatL Acad. Sci. USA (1992) 89:11745–11749.
  • MASON HS, BALL JM, SHI JJ, JIANG X, ESTES MK, ARNTZEN CJ: Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice. Proc. NatL Acad. Sci. USA (1996) 93:5335–5340.
  • HORN ME, PAPPU KM, BAILEY MR et al.: Advantageous features of plant-based systems for the development of HIV vaccines. J. Drug Target. (2003) 11:539–545.
  • WENDEROTH I, VON SCHAEWEN k Isolation and characterization of plant N-acetyl glucosaminyltransferase I (GntI) cDNA sequences. Functional analyses in the Arabidopsis cgl mutant and in antisense plants. Plant PhysioL (2000) 123:1097–1108.
  • BAKKER H, BARDOR M, MOLTHOFF JW et al.: Galactose-extended glycans of antibodies produced by transgenic plants. Proc. NatL Acad. Sci. USA (2001) 98:2899–2904.
  • STREATFIELD SJ, MAYOR JM, BARKER DK et al.: 2000 congress symposium on molecular farming: development of an edible subunit vaccine in corn against enterotoxigenic strains of Escherichia coli. In vitro. Cell. Dev. Biol. Plant. (2002) 38:11–17.
  • •Food processing technology applied to a corn-based vaccine candidate.
  • TACKET CO, PASETTI MF, EDELMAN R, HOWARD JA, STREATFIELD S: Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. Vaccine (2004) 22:4385–4389.
  • ••Clinical trial using a corn product.
  • TACKET CO, MASON HS, LOSONSKY G, CLEMENTS JD, LEVINE MM, ARNTZEN CJ: Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. (1998) 4:607–609.
  • •Clinical trial using potatoes.
  • TACKET CO, MASON HS, LOSONSKY G, ESTES MK, LEVINE MM, ARNTZEN CJ: Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes. J. Infect. Dis. (2000) 182:302–305.
  • •Clinical trial using potatoes.
  • LAMPHEAR BJ, JILKA JM, KESL L, WELTER M, HOWARD JA, STREATFIELD SJ: A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine (2004) 22:2420–2424.
  • ••Swine trial using corn and demonstratinglactogenic immunity.
  • ARAKAWA T, CHONG DK, LANGRIDGE WH: Efficacy of a food plant-based oral cholera toxin B subunit vaccine. Nat. BiotechnoL (1998) 16:292–297.
  • YU J, LANGRIDGE WH: A plant-based multicomponent vaccine protects mice from enteric diseases. Nat. BiotechnoL (2001) 19:548–552.
  • •Demonstration of passive immunity.
  • WIGDOROVITZ A, MOZGOVOJ M, DUS SANTOS MJ et al.: Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants. J. Gen. ViroL (2004) 85:1825–1832.
  • •Demonstration of passive immunity.

Websites

  • http://www.prodigene.com/0501.htm ProdiGene website press release (2004).
  • http://www.ventriabio.com/news/ 12-22-04.pdf Ventria Bioscience website press release (2004).
  • http://www.fraunhofer-cmb.org/ index.cfm?act = technology Fraunhofer USA Center for Molecular Biotechnology website (technology).
  • http://www.biolex.com/technologies.html Biolex website (technologies).
  • http://www.aphis.usda.gov/brs/perm_not US D epartment of Agriculture, Animal and Plant Health Inspection Service website (genetically engineered plants and microorganisms permit procedures).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.